Media

Daiichi Sankyo Joins BioLabs San Diego as Platinum Sponsor

Download the PDF version of Article

October 07, 2025

San Diego, CA and Basking Ridge, NJ - (October 7, 2025) - Daiichi Sankyo (TSE: 4568) has joined BioLabs, the leading international innovation platform and network of premier shared laboratory spaces, as a Platinum Sponsor of BioLabs San Diego.

Located in the heart of a dynamic biotech hub, BioLabs San Diego is home to more than 50 resident companies developing breakthrough technologies. The site offers fully equipped and supported lab and office spaces, both shared and private, designed to help entrepreneurs accelerate their growth and focus on scientific innovation.

As part of this sponsorship, Daiichi Sankyo through its Daiichi Sankyo Research Institute in San Diego will provide BioLabs residents with direct access to its scientific leaders and expertise to more deeply connect with the broader scientific community and will include Golden Ticket programs that will provide selected startups with sponsored lab space at BioLabs San Diego.

“We are thrilled to welcome Daiichi Sankyo as a Platinum Sponsor of BioLabs San Diego,” said Johannes Fruehauf, Founder and CEO of BioLabs. “This marks an important milestone for BioLabs and our residents. Daiichi Sankyo is a global leader in drug discovery and development, and we are excited about the opportunities this will create for both organizations not only in San Diego, but throughout our growing network of labs.”

“At Daiichi Sankyo, we are dedicated to advancing next-generation therapeutics by fostering a vibrant and innovative research ecosystem,” said Yuki Abe, PhD, Head of R&D Division in Japan and Head of Research, Daiichi Sankyo. “Our work with BioLabs San Diego reflects our commitment to supporting early-stage scientific discovery and accelerating the development of breakthrough science to transform novel ideas into impactful medicines that address unmet medical needs.”

About BioLabs
A membership-based innovation platform and network of shared laboratories, BioLabs offers beautifully designed coworking environments that pair fully equipped and supported lab, office and event spaces with relevant programming and unparalleled access to capital and industry partners. These fertile, supportive ecosystems allow young companies to shift their focus from startup operations to experimentation and innovation so they can reach their scientific potential quickly and achieve business success. Companies can start with a single lab bench and scale up as they grow. The expanding BioLabs network currently operates labs in the US: California, Connecticut, Massachusetts, New Jersey, North Carolina, New York, Pennsylvania, Texas, and Vermont; in Europe: Paris and Saclay, France, Heidelberg, Munich and Berlin, Germany; and, in Kawasaki, Japan. Learn more at www.biolabs.io.

About Daiichi Sankyo Research Institutes
Daiichi Sankyo Research Institutes, located in Boston, Munich and San Diego, are advancing the vision of Daiichi Sankyo to foster the development of next-generation medicines by leveraging the expertise of Daiichi Sankyo scientists and building robust research innovation networks that incubate breakthrough science through advanced technology platforms and innovative disease targets.

About Daiichi Sankyo
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.com.

Media Contacts: